FDA Inspection 1224426 — Washington Hospital Center Transfusion Service
The FDA completed an inspection of Washington Hospital Center Transfusion Service on Nov 16, 2023 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Washington, DC (United States)